Back
Day Range
$8.26
$8.63
52-Week Range
$5.41
$12.49
Volume
1,010,587
50D / 200D Avg
$8.55
/
$8.54
Prev Close
$8.07
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.7 | 0.3 |
| P/B | 4.3 | 3.0 |
| ROE % | -94.8 | 3.7 |
| Net Margin % | -413.0 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$28.20
+229.8%
Low: $15.00
High: $40.00
Forward EPS
-$3.52
Est. Revenue
118.28M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.93
$0.75 – $11.59
|
1.29B | 3 |
| FY2029 |
$0.74
$0.14 – $2.18
|
738.20M | 3 |
| FY2028 |
-$1.44
-$3.62 – $3.48
|
412.65M | 9 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-05 | -$0.64 | -$0.92 | -44.0% |
| 2025-11-04 | -$0.57 | -$0.85 | -49.1% |
| 2025-08-07 | $0.15 | -$0.75 | -600.0% |
| 2025-05-01 | -$0.51 | -$0.66 | -29.4% |
| 2025-02-26 | -$0.65 | -$0.22 | +66.2% |
| 2024-11-07 | -$0.64 | -$0.63 | +1.6% |
| 2024-08-08 | -$0.63 | -$0.59 | +6.3% |
| 2024-05-02 | -$0.56 | -$0.59 | -5.4% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.12 — conservative balance sheet
Negative free cash flow of -70.70M
Capital efficient — spends only 9.84% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)25.24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-94.82%
ROIC-117.03%
Net Margin-412.95%
Op. Margin-449.94%
Safety
Debt / Equity
0.12
Current Ratio6.06
Interest Coverage-200.81
Valuation
P/E Ratio
-2.71
Forward P/EN/A
P/B Ratio4.34
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 25.24% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 67.48M | Net Income (TTM) | -278.67M |
| ROE | -94.82% | ROA | -37.74% |
| Gross Margin | 99.92% | Operating Margin | -449.94% |
| Net Margin | -412.95% | Free Cash Flow (TTM) | -70.70M |
| ROIC | -117.03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.12 | Current Ratio | 6.06 |
| Interest Coverage | -200.81 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.71 | Forward P/E | N/A |
| P/B Ratio | 4.34 | P/S Ratio | 11.19 |
| PEG Ratio | -0.06 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 26.49 |
| Forward P/S | 6.38 | Fwd Earnings Yield | N/A |
| FCF Yield | -9.36% | ||
| Market Cap | 755.22M | Enterprise Value | 626.58M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 67.48M | 53.88M | 0.0 | 0.0 | 0.0 |
| Net Income | -278.67M | -173.98M | -152.63M | -135.84M | -130.47M |
| EPS (Diluted) | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 |
| Gross Profit | 67.43M | 53.88M | -849,000.0 | 0.0 | 0.0 |
| Operating Income | -303.63M | -193.20M | -165.80M | -139.87M | -131.26M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 738.36M | 760.16M | 448.94M | 456.31M | 534.05M |
| Total Liabilities | 564.23M | 346.52M | 51.66M | 36.03M | 27.44M |
| Shareholders' Equity | 174.14M | 413.64M | 397.27M | 420.28M | 506.61M |
| Total Debt | 20.46M | 16.59M | 17.20M | 14.02M | 6.88M |
| Cash & Equivalents | 149.10M | 224.46M | 37.32M | 51.80M | 90.67M |
| Current Assets | 708.66M | 744.83M | 432.48M | 446.43M | 522.29M |
| Current Liabilities | 116.97M | 78.71M | 35.26M | 24.06M | 22.46M |